Labcorp Fentanyl Urine Visual Test
The Labcorp Fentanyl Urine Visual Test is an FDA-cleared, moderate complexity rapid urine test delivering results in 10 minutes. Designed for use by laboratory professionals, it detects norfentanyl to identify exposure and support fast clinical decisions, overdose prevention education, and timely patient care.
Long Description
The Labcorp Fentanyl Urine Visual Test is an FDA-cleared, moderate complexity rapid screening solution designed for clinical laboratories, hospitals, and emergency care environments.
Delivering results in just 10 minutes, this visual urine test detects norfentanyl—the primary fentanyl metabolite—with >96% accuracy at a 5 ng/mL cutoff and an extended detection window of up to 48 hours.
Designed to support efficient clinical workflows, the test requires no specialized laboratory equipment, enabling rapid implementation. Reliable detection while patients are still in care supports informed clinical decision-making, timely intervention, and coordination of overdose prevention strategies, including access to reversal medications and referral pathways.
Manufactured in the US by Labcorp Point of Care (formerly MEDTOX Diagnostics), the test delivers consistent performance, operational efficiency, and confidence for healthcare professionals managing suspected fentanyl exposure.
High Resolution Image
Small Image
Large Image
Category Product Showcase